These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2881052)

  • 21. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia).
    Gibb WR; Esiri MM; Lees AJ
    Brain; 1987 Oct; 110 ( Pt 5)():1131-53. PubMed ID: 2823957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortical Lewy body dementia: clinical features and classification.
    Gibb WR; Luthert PJ; Janota I; Lantos PL
    J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):185-92. PubMed ID: 2467966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological aspects of Parkinson's disease.
    Hughes AJ
    Eur Neurol; 1997; 38 Suppl 2():13-20. PubMed ID: 9387798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dementia with cerebral Lewy bodies. A mesocortical dopaminergic defect?
    Eggertson DE; Sima AA
    Arch Neurol; 1986 May; 43(5):524-7. PubMed ID: 3964123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An autopsy case of idiopathic parkinsonism with numerous Lewy bodies in the cerebral cortex--diffuse Lewy body disease].
    Akashi T; Maruyama N; Sawayama H
    No To Shinkei; 1991 Feb; 43(2):175-81. PubMed ID: 1651748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of amyloid-beta deposition in the cerebral cortex in Parkinson's disease.
    Mastaglia FL; Johnsen RD; Byrnes ML; Kakulas BA
    Mov Disord; 2003 Jan; 18(1):81-6. PubMed ID: 12518303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
    Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffuse Lewy body disease: an important differential diagnosis in dementia with extrapyramidal features.
    Lennox G; Lowe JS; Godwin-Austen RB; Landon M; Mayer RJ
    Prog Clin Biol Res; 1989; 317():121-30. PubMed ID: 2602409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re: Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Brenner SR
    Neurology; 2008 Jun; 70(23):2265; author reply 2265. PubMed ID: 18519878
    [No Abstract]   [Full Text] [Related]  

  • 30. [From Parkinson's disease to Lewy body disease].
    Bordet R; Destée A
    Presse Med; 1992 Apr; 21(15):708-12. PubMed ID: 1534893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease.
    Hurtig HI; Trojanowski JQ; Galvin J; Ewbank D; Schmidt ML; Lee VM; Clark CM; Glosser G; Stern MB; Gollomp SM; Arnold SE
    Neurology; 2000 May; 54(10):1916-21. PubMed ID: 10822429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.
    Iannaccone S; Cerami C; Alessio M; Garibotto V; Panzacchi A; Olivieri S; Gelsomino G; Moresco RM; Perani D
    Parkinsonism Relat Disord; 2013 Jan; 19(1):47-52. PubMed ID: 22841687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical features of Parkinson's disease in 100 histologically proven cases.
    Hughes AJ; Daniel SE; Lees AJ
    Adv Neurol; 1993; 60():595-9. PubMed ID: 8420197
    [No Abstract]   [Full Text] [Related]  

  • 35. Parkinson's disease dementia: what's in a Lewy body?
    Burn DJ
    J Neural Transm Suppl; 2006; (70):361-5. PubMed ID: 17017554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid beta-peptide and the dementia of Parkinson's disease.
    Jendroska K; Lees AJ; Poewe W; Daniel SE
    Mov Disord; 1996 Nov; 11(6):647-53. PubMed ID: 8914090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffuse Lewy body disease: an autopsy case.
    Kuroda S; Otsuki S; Hayashi Y
    Acta Med Okayama; 1987 Jun; 41(3):133-9. PubMed ID: 2820201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cerebral atrophy and dementia in Parkinson disease].
    Corthésy D; Hungerbühler JP; Assal G; Regli F
    Schweiz Arch Neurol Psychiatr (1985); 1985; 136(1):75-85. PubMed ID: 2579429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiopathic Parkinson's disease and the Lewy body disorders.
    Gibb WR
    Neuropathol Appl Neurobiol; 1986; 12(3):223-34. PubMed ID: 3016582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progressive dementia with parkinsonism in corticobasal and brainstem degeneration with neuronal inclusions.
    Behring B; Beuche W; Kretzschmar HA
    Neurology; 1998 Jul; 51(1):285-8. PubMed ID: 9674824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.